In Vitro Diagnostic Industry in China - Diagnosis of Blood and Body Fluids X

2.3 Development of Domestic Coagulation Enterprises

With the development of the blood coagulation industry, more and more IVD companies have joined it and actively expanded the related services.

•   In 2006, Succeeder started to enter the coagulation testing market and launched the first set of domestic fully automated coagulation analyzer SF-8000, breaking the monopoly of imported products on the Chinese market.

•   In 2012, Maccura began to enter the blood coagulation market and successively launched semi-automated and fully automated coagulation analyzers.

•   On October 31, 2012, Mindray became the dominating shareholding company of Prismlab. On January 9, 2014, Mindray and Long Island Biotech reached an equity transfer to control Long Island. With the joining of Prismlab and Long Island Biotech, Mindray has owned a platform for the R&D, production and sales of thrombosis and hemostasis business, and expanded its IVD channels, catering to the ever-growing market trend for the detection of cardiovascular-related diseases.

•   In 2016, Shenzhen Ultra-Diagnostics Biotec. Co., Ltd. was founded, specializing in the research and development, manufacturing, and sales of IVD instruments and supporting reagents, and dedicated to providing overall solutions for the thrombus and hemostasis diagnostic products.

•   On October 31, 2016, Thalys, which owns the coagulation business, was listed on the Shanghai Stock Exchange.

•   On May 2, 2017, BSBE acquired 100% equity in Innovative Medcare Technology Ltd. After Innovative Medcare Technology Ltd’s joining, BSBE has a complete production line of coagulation analysis instruments and reagents, which is a supplement to the existing IVD system and forms a more complete production line, thereby offering better services to customers.

•   In 2018, Wondfo launched an instant coagulation analyzer, which can detect routine four items plus ACT.

•   In 2019, BSBE successfully launched the first set of domestic fully automated coagulation analyzer MDC3500, taking a solid step into the blood coagulation market.

•   In 2019, Dirui successfully launched its first set of coagulation analyzer and supporting reagents, officially entering the coagulation analysis market.

•   On July 24, 2020, Getein Biotech officially released the Progress Announcement on the Proposed Acquisition of Partial Shares of Wuhan King Diagnostic Technology Co., Ltd. and Capital Increase, to enter the segment of blood coagulation testing industry and start its business segment of coagulation testing.

•   On August 6, 2020, Succeeder was officially listed on the Shanghai Stock Exchange STAR Market and became the first listed company of the coagulation industry in China.

Last: In Vitro Diagnostic Industry in China - Diagnosis of Blood and Body Fluids IX